These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic effect of lisuride in advanced Parkinson's disease. Meneghetti G; Bracco F; Giometto B; Ferla S; Schergna E Eur Neurol; 1986; 25(1):74-80. PubMed ID: 3510126 [TBL] [Abstract][Full Text] [Related]
3. Lisuride, a dopamine agonist in the treatment of early Parkinson's disease. Rinne UK Neurology; 1989 Mar; 39(3):336-9. PubMed ID: 2927639 [TBL] [Abstract][Full Text] [Related]
5. Lisuride in Parkinson disease: efficacy of lisuride compared to levodopa. Lieberman A; Goldstein M; Neophytides A; Kupersmith M; Leibowitz M; Zasorin N; Walker R; Kleinberg D Neurology; 1981 Aug; 31(8):961-5. PubMed ID: 7022259 [TBL] [Abstract][Full Text] [Related]
6. Lisuride in the treatment of Parkinsonism. Schachter M; Sheehy MP; Parkes JD; Marsden CD Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157 [TBL] [Abstract][Full Text] [Related]
7. [Lisuride in the combination treatment of Parkinson disease]. Jellinger K Wien Med Wochenschr; 1987 Apr; 137(7-8):155-9. PubMed ID: 3111099 [TBL] [Abstract][Full Text] [Related]
8. Combination of a dopamine agonist, MAO-B inhibitor and levodopa--a new strategy in the treatment of early Parkinson's disease. Rinne UK Acta Neurol Scand Suppl; 1989; 126():165-9. PubMed ID: 2515722 [TBL] [Abstract][Full Text] [Related]
9. Bromocriptine and lisuride in Parkinson disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Walker R; Hiesiger E Ann Neurol; 1983 Jan; 13(1):44-7. PubMed ID: 6830164 [TBL] [Abstract][Full Text] [Related]
10. Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients. Rabey JM; Treves T; Streifler M; Korczyn AD Adv Neurol; 1987; 45():569-72. PubMed ID: 3825734 [No Abstract] [Full Text] [Related]
11. [Oral lisuride in Parkinson's disease]. Obeso JA; Luquin MR; MartÃnez Lage JM Med Clin (Barc); 1985 Sep; 85(8):307-12. PubMed ID: 4068822 [No Abstract] [Full Text] [Related]
12. Further studies with lisuride in Parkinson's disease. Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E Eur Neurol; 1983; 22(2):119-23. PubMed ID: 6341071 [TBL] [Abstract][Full Text] [Related]
13. Lisuride combined with levodopa in advanced Parkinson disease. Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504 [TBL] [Abstract][Full Text] [Related]
14. The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. Lieberman AN; Leibowitz M; Gopinathan G; Walker R; Hiesiger E; Nelson J; Goldstein M Am J Med Sci; 1985 Sep; 290(3):102-6. PubMed ID: 4050844 [TBL] [Abstract][Full Text] [Related]
15. Lisuride in the treatment of parkinsonism. McDonald RJ; Horowski R Eur Neurol; 1983; 22(4):240-55. PubMed ID: 6884394 [TBL] [Abstract][Full Text] [Related]
16. Effects of lisuride on blink reflex habituation in Parkinson disease. Sandrini G; Alfonsi E; Martignoni E; Horowski R; Nappi G Eur Neurol; 1985; 24(6):374-9. PubMed ID: 4065156 [TBL] [Abstract][Full Text] [Related]
17. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
18. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
20. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]